We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

Pragmatic Semiconductor, the UK developer of IGZO (Indium gallium zinc oxide)-based FlexIC devices, has appointed Steve McCue ...

The medical sector is one of the major adopters of artificial intelligence (AI), which is currently being used to synthesize ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Verastem (VSTM – Research Report) today and set a price target of $9.00.

Godrej Properties Ltd has purchased ~10 acres of land in Yelahanka, Bengaluru to develop ~1.5 million square feet of saleable ...

A medical expert explained the non-pharmaceutical ways to lower cholesterol levels after a patient said they didn't like the ...

Due to hemophilia A patients switching to newer treatments, Takeda Pharmaceuticals is discontinuing both Hemofil M and Recombinate globally.

Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Icon Public Limited (NASDAQ:ICLR) stock and Charles River Laboratories (NYSE:CRL) stock trade lower as Goldman Sachs ...

Fintel reports that on March 21, 2025, Goldman Sachs downgraded their outlook for ICON Public Limited (NasdaqGS:ICLR) from ...

(Reuters) -Johnson & Johnson said on Friday it plans to invest more than $55 billion over the next four years to build ...